KAI Research

Name

KAI Research

Website

https://kai-research.com

Company type

Private

Founded year

1986

Operating status

Operating

Short description

KAI Research is described as a full-service contract research organization (CRO) and health research company founded in 1986, headquartered in Rockville, United States, though its primary domain is currently parked.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) / Clinical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (541)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Contract research organization
• Clinical research services
• Health research
• Clinical trials
• Pharmaceutical research

Headquarters

HQ city

Rockville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Core offering

KAI Research is a full-service contract research organization (CRO) and health research company providing outsourced clinical and health research services. The firm was founded in 1986 and is headquartered in Rockville, Maryland, serving clients in the healthcare and life sciences sectors.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Research Organization (CRO) Services

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Parexel International: Mid-to-large global CRO offering full-service clinical development, regulatory consulting, and post-approval services. A relevant incumbent comparable to KAI Research's stated full-service CRO positioning.
• IQVIA: The largest global full-service CRO and life-sciences analytics firm. IQVIA competes for the same multi-service sponsor contracts that KAI Research would target, and serves as the upper bound for what a scaled full-service CRO can achieve.
• ICON plc: Major global CRO offering full-service clinical development, laboratory, and consulting services. ICON's post-PRA merger scale and full-service positioning make it a direct comparator for any U.S.-based full-service CRO.
• Charles River Laboratories: Large CRO providing preclinical and clinical research services, including laboratory and safety testing. Comparable to KAI Research across the discovery-through-clinical continuum for biopharma sponsors.
• Labcorp Drug Development (formerly Covance): Integrated CRO with extensive central-laboratory capabilities. Closely comparable to KAI Research's full-service health-research positioning, with strong overlap in clinical trial testing and central lab work.

Direct peers

• Premier Research: Small-to-mid CRO with therapeutic-area specialization in areas such as rare disease, oncology, and CNS. Comparable to KAI Research as a similarly sized full-service competitor pursuing sponsor clinical programs.
• Worldwide Clinical Trials: Mid-size full-service CRO focused on therapeutic areas such as neuroscience, oncology, and cardiometabolic disease. A more directly comparable peer to a small/mid U.S. full-service CRO like KAI Research in terms of size and service scope.
• EMMES: Rockville, MD-based CRO historically focused on NIH and federally funded clinical trials. Highly comparable to KAI Research in terms of geography (same city), sponsor mix (government/academic), and full-service CRO offering.
• Rho: Mid-size CRO with strong federal and academic sponsor relationships, including NIH-funded work, headquartered in the Research Triangle. A close functional analog to KAI Research in serving government and academic health-research sponsors.

Regional players

• Clinical Research Services (CRS): Smaller CRO serving academic, government, and biopharma sponsors with clinical operations and data services. Comparable as a small full-service CRO competitor in the U.S. clinical-trial services market.

Market position

Customer concentration

• LinkedInlinkedin.com/company/kai-research-inc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KAI Research